CD274 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), solute carrier family 25 member 15 (SLC25A15) is hypoxia-responsive with low glutamine reprogramming, facilitating anti-PD-L1 therapy (Zhang Q. et al., 2024).